AI assistant
GlaxoSmithKline PLC — Director's Dealing 2015
Oct 19, 2015
5262_dirs_2015-10-19_2583791b-649a-4d02-9dea-b1babf283d53.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 7116C
GlaxoSmithKline PLC
19 October 2015
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of changes in the interests of the following Directors and Persons Discharging Managerial Responsibilities ('PDMR') who acquired Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a price of 1294.81 pence per Share, following the re-investment of the dividend paid to shareholders on 1 October 2015.
| Director/PDMR | Shares |
| Sir Andrew Witty | 29.783 |
| Mr R G Connor | 247.313 |
| Mr S Dingemans | 975.733 |
| Mr S A Hussain | 2,232.502 |
| Mr D S Redfern | 846.893 |
| Dr M M Slaoui | 171.202 |
| Ms C Thomas | 1,039.600 |
| Mr P C Thomson | 355.850 |
| Dr P J T Vallance | 1,260.356 |
| Ms E Walmsley | 977.510 |
| Connected Person | Shares |
| Mrs K Thomson (Connected Person to Mr P C Thomson) | 114.588 |
GSK was informed of these allocations on 16 October 2015.
V A Whyte
Company Secretary
19 October 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSXKLFFEBFXFBX